期刊文献+

多发性骨髓瘤细胞系CZ-1的建立及其生物学特性 被引量:5

Establishment and biological characteristics of human multiple myeloma cell line CZ-1
原文传递
导出
摘要 目的 建立多发性骨髓瘤 (MM)细胞系并鉴定其生物学特性。方法 分离 1例晚期λ轻链型MM患者外周血和骨髓的单个核细胞 ,用液体培养法进行培养。用瑞特 姬姆萨染色和细胞化学染色确定细胞形态 ;用免疫固定电泳技术检测细胞是否分泌单克隆λ轻链 ,用荧光定量PCR法检测细胞是否被EB病毒感染 ;用流式细胞仪分析细胞的免疫表型 ;用染色体G分带法研究细胞的遗传学特征。结果 所得细胞系在饲养细胞或条件培养液存在时 ,可以持久增殖。该细胞分泌λ轻链 ,EB病毒阴性 ;细胞在瑞特 姬姆萨染色下呈典型的原、幼浆细胞形态 ;细胞化学染色 :酸性磷酸酶染色 (+) ,髓过氧化物酶 (- ) ;细胞免疫表型为CD1 0+,CD2 8+,CD3 8+,CD1 3 8+,CD56+,CD49d+,CD54+,CD44+,CD58+,而不表达CD1 9,CD40 ,CD95,CD95L ,CD3 4 ,CD2 ,CD5。骨髓来源和外周血来源的细胞系免疫表型无明显不同 ,核型分析结果均为i(1q +) ,8q +,13q +,i(17q) ,i(18q) ,+M。结论 用 1例MM患者的外周血和骨髓细胞同时建立了一个生物学特性相同的分泌λ轻链的MM细胞系CZ 1。 Objective To establish a multiple myeloma (MM) cell line and analyze its biological characteristics. Methods Mononuclear cells isolated from the peripheral blood(PB) and bone marrow(BM) of an advanced MM patient (λ light chain type) were incubated by liquid cell culture,cell morphology was analyzed by Wright-Giemsa-staining and cytochemical staining, immunophenotyping by flow cytometry, cytogenetic analysis by chromosome RHG-banding method.Quantitative fluorescent polymerase chain reaction was used to detect EBV DNA. Results The established cell line could survive and proliferate in the presence of feeder cells or conditioned medium. The cells secreted λ light chain and were negative for EBV. The Wright-Giemsa-staining showed typical plasmablast or plasma cell morphology. The cytochemical staining of the cells showed the following reactivity pattern:positive for acid phosphatase, negative for myeloperoxidase. The immunoprofile of the cells was concordant with that of MM cells: positive for CD 10,CD 28,CD 38,CD 138,CD 56,CD 49d,CD 44,CD 54 and CD 58,negative for CD 19,CD 40,CD 95,CD 95L,CD 34, CD 2 and CD 5. The cytogenetic analysis showed complex chromosome abnormality of i(1q+),8q+,13q+,i(17q),i(18q) and +M. There was no difference in morphology, immunophenotype and cytogenetics between cells from PB and BM. Conclusion A MM cell line secreting λ light chain named CZ-1,was established.The cells from both PB and BM have the same biological characteristics.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2002年第10期509-513,共5页 Chinese Journal of Hematology
关键词 多发性骨髓瘤 细胞系 生物学特性 Multiple myeloma Cell line Biological characteristics
  • 相关文献

参考文献13

  • 1Matsuoka Y,Moore GE,Yage Y,et al. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med,1967,125:1246-1250.
  • 2Drexler HG, Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk Res,2000,24 :681-703.
  • 3张和君 郭仁.三例人骨髓瘤细胞株的建立[J].细胞生物学杂志,1998,2:88-88.
  • 4Zhang XG, Gaillard JP, Robillard N,et al. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood, 1994,83:3654-3663.
  • 5Matsuo Y,Drexler HG,Nishizaki C,et al. Human bone marrow stroma-dependent cell line,MOLP-5,derived from a patient in leukemia phase of multiple myeloma. Br J Haematol ,2000,109:54-63.
  • 6Uchiyama H, Barut BA, Mohrbacher AF, et al. Adhesion of human myeloma -derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood, 1993, 82: 3712-3720.
  • 7Chauhan D, Uchiyama H, Akbarali Y, et al. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B. Blood, 1996, 87: 1104-1112.
  • 8Harada H, Kawano MM, Huang N, et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood, 1993, 81: 2658-2663.
  • 9Tong AW, Zhang BQ, Mues G, et al. Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro. Blood, 1994, 84:3026-3033.
  • 10Urashima M, Chauhan D, Uchiyama H, et al. CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood, 1995,85: 1903-1912.

同被引文献49

  • 1薛永权 过宇.介绍一种改良的骨髓细胞染色体热变性姬姆萨R显带法[J].中华医学检验杂志,1986,9:247-247.
  • 2Pallarès N,Lefebvre S,Contet V,et al.The human immunoglobulin heavy variable genes.Exp Clin Immunogenet,1999,16(1):36-60.
  • 3Drexler HG,Matsuo Y.Malignant helnatopoietie cell lines:in vitro models for the study of multiple myeloma and plasma cell leukemia.Leuk Res,2000,24(8):681-703.
  • 4Neitzel H.A routine method for the establishment of permanent growing lymphoblastoid cell lines.Hum Genet,1986,73(4):320-326.
  • 5Takahashi T,Kawabe T,Okazaki Y,et al.In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.DNA Cell Biol,2003,22(11):727-735.
  • 6Lee ST,Jiang YE Park KU,et al.BiovaxID:a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.Expert Opin Biol Ther,2007,7(1):113-122.
  • 7Trojan A,Schultze JL.Witzens M,et al.Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies.Nat Med,2000,6(6):667-672.
  • 8Xiaoling G,Ying L,Jing L,et al.Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain.Cancer Immunol Immunother,2005,54(11):1106-1114.
  • 9Robson NC,McAlpine T,Knights AJ,et al.Processing and cross-presentation of individual HLA-A,-B or -C epitopes from NY-ESO-1 or a HLA-A epitope for Melan-A differ according to the mode of antigen delivery.Blood,2010,116(2):218-225.
  • 10Howell WM,Carter V,Clark B.The HLA system:immunobiology,HLA typing,antibody screening and crossmatching techniques.J Clin Pathol,2010,63(5):387-390.

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部